ATE268166T1 - Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol - Google Patents
Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterolInfo
- Publication number
- ATE268166T1 ATE268166T1 AT98944834T AT98944834T ATE268166T1 AT E268166 T1 ATE268166 T1 AT E268166T1 AT 98944834 T AT98944834 T AT 98944834T AT 98944834 T AT98944834 T AT 98944834T AT E268166 T1 ATE268166 T1 AT E268166T1
- Authority
- AT
- Austria
- Prior art keywords
- salmeterol
- compositions
- treatment
- optically pure
- lung diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/931,636 US6254882B1 (en) | 1997-09-16 | 1997-09-16 | Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol |
PCT/US1998/018845 WO1999013867A1 (en) | 1997-09-16 | 1998-09-10 | Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE268166T1 true ATE268166T1 (de) | 2004-06-15 |
Family
ID=25461118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98944834T ATE268166T1 (de) | 1997-09-16 | 1998-09-10 | Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol |
Country Status (19)
Country | Link |
---|---|
US (1) | US6254882B1 (de) |
EP (1) | EP1007008B1 (de) |
JP (1) | JP2001516715A (de) |
KR (1) | KR20010030610A (de) |
CN (1) | CN1270515A (de) |
AT (1) | ATE268166T1 (de) |
AU (1) | AU754275B2 (de) |
BG (1) | BG104240A (de) |
BR (1) | BR9812643A (de) |
CA (1) | CA2304265A1 (de) |
CZ (1) | CZ290394B6 (de) |
DE (1) | DE69824296T2 (de) |
ES (1) | ES2221991T3 (de) |
HU (1) | HUP0003488A3 (de) |
IL (1) | IL135022A0 (de) |
NO (1) | NO20001343D0 (de) |
NZ (1) | NZ503563A (de) |
SK (1) | SK3722000A3 (de) |
WO (1) | WO1999013867A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
PT1212089E (pt) * | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
GB9924992D0 (en) * | 1999-10-21 | 1999-12-22 | Glaxo Group Ltd | Pharmaceutical aerosol formulations |
EP1523976A3 (de) * | 1999-11-23 | 2005-06-22 | Glaxo Group Limited | Pharmazeutische Formulierungen enthaltend Salmeterol |
WO2003024396A2 (en) | 2001-09-17 | 2003-03-27 | Glaxo Group Limited | Dry powder medicament formulations |
US7378438B2 (en) * | 2002-04-19 | 2008-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
EP1562975A2 (de) * | 2002-10-25 | 2005-08-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten |
EP1624866A2 (de) * | 2003-05-16 | 2006-02-15 | Arriva Pharmaceuticals, Inc. | Behandlung von atemwegserkrankungen durch inhalation von syntetischen matrix metalloprotease inhibitoren |
WO2004112791A1 (ja) * | 2003-06-23 | 2004-12-29 | Kyowa Hakko Kogyo Co., Ltd. | 肺疾患の治療および/または予防剤 |
PL1719507T3 (pl) * | 2005-04-13 | 2010-12-31 | Cipher Pharmaceuticals Inc | Agoniści receptora beta2-adrenergicznego do leczenia chorób tkanki łącznej skóry |
US9119777B2 (en) | 2008-05-30 | 2015-09-01 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
US8415390B2 (en) * | 2008-05-30 | 2013-04-09 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZW6584A1 (en) | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
IL95936A (en) | 1989-10-10 | 1996-01-19 | Glaxo Group Ltd | ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it |
GB9024366D0 (en) | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
GB9026005D0 (en) | 1990-11-29 | 1991-01-16 | Glaxo Group Ltd | Drug material suitable for micronisation |
GB9107196D0 (en) | 1991-04-05 | 1991-05-22 | Sandoz Ag | Improvements in or relating to organic compounds |
NZ500250A (en) * | 1997-04-30 | 2001-03-30 | Bridge Pharma Inc | Adrenergic beta-2 agonist eutomers, feed compositions and use for increasing muscle and decreasing fat |
-
1997
- 1997-09-16 US US08/931,636 patent/US6254882B1/en not_active Expired - Fee Related
-
1998
- 1998-09-10 WO PCT/US1998/018845 patent/WO1999013867A1/en not_active Application Discontinuation
- 1998-09-10 AT AT98944834T patent/ATE268166T1/de not_active IP Right Cessation
- 1998-09-10 SK SK372-2000A patent/SK3722000A3/sk unknown
- 1998-09-10 HU HU0003488A patent/HUP0003488A3/hu unknown
- 1998-09-10 IL IL13502298A patent/IL135022A0/xx unknown
- 1998-09-10 ES ES98944834T patent/ES2221991T3/es not_active Expired - Lifetime
- 1998-09-10 BR BR9812643-1A patent/BR9812643A/pt not_active IP Right Cessation
- 1998-09-10 EP EP98944834A patent/EP1007008B1/de not_active Expired - Lifetime
- 1998-09-10 AU AU92283/98A patent/AU754275B2/en not_active Ceased
- 1998-09-10 DE DE69824296T patent/DE69824296T2/de not_active Expired - Fee Related
- 1998-09-10 JP JP2000511490A patent/JP2001516715A/ja not_active Withdrawn
- 1998-09-10 NZ NZ503563A patent/NZ503563A/en unknown
- 1998-09-10 CZ CZ2000916A patent/CZ290394B6/cs not_active IP Right Cessation
- 1998-09-10 KR KR1020007002801A patent/KR20010030610A/ko active IP Right Grant
- 1998-09-10 CN CN98809163A patent/CN1270515A/zh active Pending
- 1998-09-10 CA CA002304265A patent/CA2304265A1/en not_active Abandoned
-
2000
- 2000-03-14 BG BG104240A patent/BG104240A/xx unknown
- 2000-03-15 NO NO20001343A patent/NO20001343D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP1007008A1 (de) | 2000-06-14 |
BG104240A (en) | 2001-04-30 |
NO20001343L (no) | 2000-03-15 |
HUP0003488A3 (en) | 2003-05-28 |
US6254882B1 (en) | 2001-07-03 |
DE69824296D1 (de) | 2004-07-08 |
CZ290394B6 (cs) | 2002-07-17 |
HUP0003488A2 (hu) | 2001-02-28 |
NZ503563A (en) | 2002-07-26 |
NO20001343D0 (no) | 2000-03-15 |
SK3722000A3 (en) | 2000-07-11 |
CZ2000916A3 (cs) | 2000-08-16 |
ES2221991T3 (es) | 2005-01-16 |
IL135022A0 (en) | 2001-05-20 |
KR20010030610A (ko) | 2001-04-16 |
EP1007008B1 (de) | 2004-06-02 |
JP2001516715A (ja) | 2001-10-02 |
BR9812643A (pt) | 2000-08-22 |
AU754275B2 (en) | 2002-11-07 |
EP1007008A4 (de) | 2002-06-12 |
CN1270515A (zh) | 2000-10-18 |
WO1999013867A1 (en) | 1999-03-25 |
AU9228398A (en) | 1999-04-05 |
CA2304265A1 (en) | 1999-03-25 |
DE69824296T2 (de) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69133576D1 (de) | Verfahren zur Herstellung von Enantiomerisch reine Beta-D-Dioxolan-Nukleoside | |
ATE268166T1 (de) | Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol | |
DE69118359D1 (de) | Optisch reines r(-)albuterol zur behandlung von asthma | |
DK144694A (da) | Fremgangsmåde til fremstilling af en optisk ren enantiomer af formoterol | |
DE59608829D1 (de) | Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden | |
DK0787715T3 (da) | Fremgangsmåde til racematspaltning af tramadol | |
DE69635305D1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
DE69502675D1 (de) | Verfahren zur Herstellung von Bis(Aminomethyl)Cyclohexan | |
DE69828191D1 (de) | Verfahren zur herstellung von 2,6-dialkylnaphthalin | |
ATE397088T1 (de) | Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e | |
ATE232387T1 (de) | Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes | |
DE69717205D1 (de) | Verfahren zur Herstellung von Wasserstoff enthaltenden fluorinierten Alkanen | |
DE50309260D1 (de) | Verfahren zur herstellung von bicalutamid | |
DE59601601D1 (de) | Verfahren zur Reindarstellung von trans- und cis-4-Hydroxy-2,2,6-trimethyl-cyclohexan-1-on aus Isomerengemischen | |
DE59600661D1 (de) | Verfahren zur Herstellung von d,I-Menthol | |
ATE411281T1 (de) | Verfahren zur herstellung von s-aryl-cystein | |
ATE339423T1 (de) | Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält | |
DE69009394D1 (de) | Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon. | |
DE69410222D1 (de) | Verfahren zur Herstellung von optisch aktiven Erythro-3-amino-1,2-epoxy-Verbindungen | |
DE59802620D1 (de) | Verfahren zur Herstellung von trans-(R,R)-Actinol | |
DE69223880D1 (de) | Verfahren zur Herstellung von gereinigtem 3,4-Epoxycyclohexyl-Methyl (Meth)Acrylat . | |
DE69802329D1 (de) | Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen | |
DE69107897D1 (de) | Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid). | |
DE60201223D1 (de) | Verfahren zur Herstellung von 3,4-Dihydroxybenzonitril | |
DE69718690D1 (de) | Verfahren zur Herstellung von optisch-aktivem 2-halogen-1-(substituiertes Phenyl)ethanol. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |